BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29329001)

  • 1. Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin
    Li Z; Wang X; Teng D; Mao R; Hao Y; Yang N; Chen H; Wang X; Wang J
    Eur J Med Chem; 2018 Feb; 145():263-272. PubMed ID: 29329001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Antibacterial Activity of the Marine Peptide N6 against Intracellular Salmonella Typhimurium by Conjugating with the Cell-Penetrating Peptide Tat
    Li Z; Teng D; Mao R; Wang X; Hao Y; Wang X; Wang J
    J Med Chem; 2018 Sep; 61(17):7991-8000. PubMed ID: 30095906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial properties of Latarcin 1 derived cell-penetrating peptides.
    Budagavi DP; Chugh A
    Eur J Pharm Sci; 2018 Mar; 115():43-49. PubMed ID: 29329747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted and Intracellular Antibacterial Activity against
    Li J; Shang L; Lan J; Chou S; Feng X; Shi B; Wang J; Lyu Y; Shan A
    ACS Appl Mater Interfaces; 2020 Oct; 12(40):44459-44474. PubMed ID: 32924418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial efficacy of in-house designed cell-penetrating peptide against multi-drug resistant strains of Salmonella Enteritidis and Salmonella Typhimurium.
    Nishanth MAD; Bhoomika S; Gourkhede D; Dadimi B; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
    Environ Microbiol; 2022 Jun; 24(6):2747-2758. PubMed ID: 34528343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating antimicrobial peptides - prospectives for targeting intracellular infections.
    Bahnsen JS; Franzyk H; Sayers EJ; Jones AT; Nielsen HM
    Pharm Res; 2015 May; 32(5):1546-56. PubMed ID: 25777610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic modification improves the delivery of cell-penetrating peptides to eliminate intracellular pathogens in animals.
    Tang Q; Tan P; Dai Z; Wang T; Xu S; Ding Y; Jin J; Zhang X; Zhang Y; Zhou C; Yue Z; Fu H; Yan J; Ma X
    Acta Biomater; 2023 Feb; 157():210-224. PubMed ID: 36503077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity.
    Drexelius M; Reinhardt A; Grabeck J; Cronenberg T; Nitsche F; Huesgen PF; Maier B; Neundorf I
    Biochem J; 2021 Jan; 478(1):63-78. PubMed ID: 33313751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.
    Oh D; Sun J; Nasrolahi Shirazi A; LaPlante KL; Rowley DC; Parang K
    Mol Pharm; 2014 Oct; 11(10):3528-36. PubMed ID: 25157458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens.
    Gomarasca M; F C Martins T; Greune L; Hardwidge PR; Schmidt MA; Rüter C
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes.
    Li L; Shi Y; Cheserek MJ; Su G; Le G
    Appl Microbiol Biotechnol; 2013 Feb; 97(4):1711-23. PubMed ID: 22923068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting intracellular pathogenic bacteria with unnatural proline-rich peptides: coupling antibacterial activity with macrophage penetration.
    Kuriakose J; Hernandez-Gordillo V; Nepal M; Brezden A; Pozzi V; Seleem MN; Chmielewski J
    Angew Chem Int Ed Engl; 2013 Sep; 52(37):9664-7. PubMed ID: 23960012
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel covalent approach to bio-conjugate silver coated single walled carbon nanotubes with antimicrobial peptide.
    Chaudhari AA; Ashmore D; Nath SD; Kate K; Dennis V; Singh SR; Owen DR; Palazzo C; Arnold RD; Miller ME; Pillai SR
    J Nanobiotechnology; 2016 Jul; 14(1):58. PubMed ID: 27412259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells.
    Moghaddam MM; Barjini KA; Ramandi MF; Amani J
    World J Microbiol Biotechnol; 2014 May; 30(5):1533-40. PubMed ID: 24323118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
    Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.
    Budagavi DP; Zarin S; Chugh A
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):250-256. PubMed ID: 29108892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical property and in vivo efficacies of novel Val/Arg-rich antimicrobial peptide.
    Ma QQ; Dong N; Shan AS; Wang L; Hu WN; Sun WY
    Protein Pept Lett; 2012 Nov; 19(11):1144-8. PubMed ID: 22587781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-cell-penetrating peptide conjugates targeting challenging drug-resistant and intracellular pathogenic bacteria.
    Zeiders SM; Chmielewski J
    Chem Biol Drug Des; 2021 Nov; 98(5):762-778. PubMed ID: 34315189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.